Phase 3 study for people with Psoriasis

Recruiting Phase 3

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Phase 3
Sponsor Bristol-Myers Squibb
Registry number NCT04772079
Started 23 March 2021 Today 16 October 2026 Estimated completion 1 January 2029

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
Local Institution - 0020 Darlinghurst NSW Active not recruiting
Local Institution - 0002 Westmead NSW Withdrawn
Queensland Children's Hospital Brisbane QLD Recruiting
Local Institution - 0003 Woolloongabba QLD Completed
Monash Health Clayton VIC Recruiting
Local Institution - 0001 Melbourne VIC Completed

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age 4 Years to 18 Years
Sex Anyone, regardless of sex
Healthy volunteers Not accepted
Enrolment target 153

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria

* Males and females aged 12 to \<18 years for Cohort 1. Males and females aged 4 to \<12 years for Cohort 2.

* Plaque psoriasis for at least 6 months.

* Moderate to severe disease.

* Candidate for phototherapy or systemic therapy.

* Must have completed the Week 52 treatment period in Part A or B for long-term extension (LTE) period.

Exclusion Criteria

* Participants weighing ≤ 30.0 kg at screening for Cohort 1 (age 12 to \< 18 years), Part A and Part B. Participants weighing \< 18.0 kg at screening for Cohort 2 (age 4 to \< 12 years), Part A and Part B.

* Other forms of psoriasis.

* History of recent infection.

* Prior exposure to deucravacitinib (BMS-986165) or another active comparator.

* Evidence of active TB for LTE period.

* Other protocol-defined inclusion/exclusion criteria apply.

Dates on the record

Started 23 March 2021
Estimated completion 1 January 2029
Registry last updated 18 August 2026
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 18 August 2026.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.